BEHANDLUNG EINER CLOSTRIDIUM DIFFICILE INFEKTION

European patent · EP3836946 · In force

Register entry

Publication number
EP3836946
Application number
EP19849346
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 16, 2019
Published
Jun 23, 2021
Granted
Apr 22, 2026
Protection ends at the latest
Aug 15, 2039
Next annual fee due
Aug 31, 2027
IPC classes
A61K 35/74 (2015.01)
A61K 35/742 (2015.01)
A61P 1/00 (2006.01)
A61P 31/04 (2006.01)
Priority
US 201862765165 P 17.08.2018
US 201862724185 P 29.08.2018
US 201962815395 P 08.03.2019
US 201962829513 P 04.04.2019
US 201962829959 P 05.04.2019
PCT application
PCT/US2019/046926 16.08.2019
PCT publication
WO2020/037271 20.02.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Jun 30, 2026

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 30.06.2026

  3. Apr 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.04.2026

Parties

Holder

Vedanta Biosciences, Inc.

19 Blackstone Street, Cambridge, MA 02139, US

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

NORMAN, Jason

Weymouth, MA 02191, US

OLLE, Bernat

Cambridge, MA 02139, US

ROBERTS, Bruce

Framingham, Massachusetts 01701, US

MENON, Rajita

Brighton, Massachusetts 02135, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.